No abstract available
MeSH terms
-
Angioplasty, Balloon, Coronary* / adverse effects
-
Angioplasty, Balloon, Coronary* / instrumentation
-
Aryl Hydrocarbon Hydroxylases / genetics
-
Aryl Hydrocarbon Hydroxylases / metabolism
-
Clopidogrel
-
Cytochrome P-450 CYP2C19
-
Drug Resistance
-
Drug Therapy, Combination
-
Genotype
-
Humans
-
Myocardial Ischemia / blood
-
Myocardial Ischemia / therapy*
-
Patient Selection
-
Phenotype
-
Platelet Aggregation / drug effects*
-
Platelet Aggregation Inhibitors / administration & dosage
-
Platelet Aggregation Inhibitors / pharmacokinetics
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Risk Assessment
-
Risk Factors
-
Stents
-
Ticlopidine / administration & dosage
-
Ticlopidine / analogs & derivatives*
-
Ticlopidine / pharmacokinetics
-
Ticlopidine / therapeutic use
-
Treatment Outcome
Substances
-
Platelet Aggregation Inhibitors
-
Clopidogrel
-
Aryl Hydrocarbon Hydroxylases
-
CYP2C19 protein, human
-
Cytochrome P-450 CYP2C19
-
Ticlopidine